Mark Sheptoff Financial Planning’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-109
Closed -$11K 391
2019
Q3
$11K Sell
109
-50
-31% -$4.75K 0.01% 271
2019
Q2
$15K Hold
159
0.01% 236
2019
Q1
$15K Hold
159
0.01% 235
2018
Q4
$10K Sell
159
-100
-39% -$7.38K 0.01% 246
2018
Q3
$23K Hold
259
0.02% 226
2018
Q2
$21K Hold
259
0.02% 223
2018
Q1
$23K Buy
259
+100
+63% +$9.6K 0.02% 224
2017
Q4
$17K Buy
159
+1
+0.6% +$113 0.01% 248
2017
Q3
$23K Hold
158
0.02% 228
2017
Q2
$21K Sell
158
-1
-0.6% -$123 0.01% 226
2017
Q1
$20K Buy
159
+1
+0.6% +$120 0.01% 228
2016
Q4
$18K Hold
158
0.01% 229
2016
Q3
$17K Hold
158
0.01% 234
2016
Q2
$16K Sell
158
-19
-11% -$1.97K 0.01% 227
2016
Q1
$18K Buy
177
+150
+556% +$15.4K 0.01% 217
2015
Q4
$3K Hold
27
﹤0.01% 325
2015
Q3
$3K Buy
27
+19
+238% +$2.36K ﹤0.01% 333
2015
Q2
$1K Buy
+8
New +$915 ﹤0.01% 388

Other funds holding CELG

Mark Sheptoff Financial Planning's CELG Position: Q4 2019 in Review

Mark Sheptoff Financial Planning sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 109 shares — an estimated $11K sold.

Mark Sheptoff Financial Planning first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $23K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mark Sheptoff Financial Planning reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 109 Celgene Corp shares in Q4 2019, an estimated $11K.
  • Mark Sheptoff Financial Planning first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • Mark Sheptoff Financial Planning's Celgene Corp position peaked at $23K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mark Sheptoff Financial Planning's 13F filing for Q4 2019, filed 10 Feb 2020.